Pfizer Opens Study Of Omicron-Specific COVID-19 Vaccine

Newsy

Published

Watch VideoPfizer has begun a study comparing its original COVID-19 vaccine with doses specially tweaked to match the hugely contagious Omicron variant. Pfizer and its partner BioNTech announced the study on Tuesday.

COVID-19 vaccine makers have been updating their shots to better match Omicron in case global health...

Full Article